TherapeuticsMD
TXMD
TXMD
149 hedge funds and large institutions have $190M invested in TherapeuticsMD in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+6
Holders Change %
+4.2%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
46
Reduced
37
Closed
19
Calls
$847K
Puts
$1.06M
Net Calls
-$209K
Net Calls Change
-$336K
Top Buyers
| 1 |
BlackRock
New York
|
+$4.16M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.06M |
| 3 |
Millennium Management
New York
|
+$952K |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$910K |
| 5 |
Squarepoint
New York
|
+$898K |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$14.7M |
| 2 |
JPMorgan Chase & Co
New York
|
-$7.76M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$6.99M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.19M |
